Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR.
Department of Ophthalmology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR; Lo Fong Siu Po Eye Centre, Grantham Hospital, Aberdeen, Hong Kong SAR.
Surv Ophthalmol. 2019 Jul-Aug;64(4):486-497. doi: 10.1016/j.survophthal.2019.01.001. Epub 2019 Jan 11.
Glaucoma, a progressive optic neuropathy, is the leading cause of irreversible blindness worldwide. Glaucoma patients are usually initially managed with medications and laser therapies, before more invasive ocular surgeries. For laser treatments of glaucoma, laser trabeculoplasty and laser transscleral cyclophotocoagulation lower the intraocular pressure by increasing the aqueous outflow and decreasing the aqueous production, respectively. The development of a subthreshold laser technique, the micropulse laser, has been investigated as a potential alternative to traditional glaucoma laser procedures, with an aim to further decrease the risk of side effects without compromising the laser treatments' efficacy. Few reviews have been done on the 2 current micropulse laser treatments for glaucoma-micropulse laser trabeculoplasty and micropulse transscleral cyclophotocoagulation. Hence, the purpose of this review was to assess the efficacy and safety of micropulse laser techniques in the treatment of glaucoma.
青光眼是一种进行性视神经病变，是全球范围内导致不可逆性失明的主要原因。青光眼患者通常首先通过药物和激光治疗进行治疗，然后再进行更具侵袭性的眼部手术。对于青光眼的激光治疗，激光小梁成形术和激光经巩膜睫状体光凝术分别通过增加房水流出和减少房水生成来降低眼内压。亚阈值激光技术——微脉冲激光的发展已被研究作为传统青光眼激光手术的一种潜在替代方法，旨在进一步降低副作用风险，而不影响激光治疗的效果。目前已有几篇关于 2 种当前用于治疗青光眼的微脉冲激光治疗方法——微脉冲激光小梁成形术和微脉冲经巩膜睫状体光凝术的综述。因此，本综述的目的是评估微脉冲激光技术治疗青光眼的疗效和安全性。
